Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101323576B reveals a green one-step synthesis of 4-nitro-1,8-naphthalic acid using CAN, offering significant cost reduction in fine chemical manufacturing and eliminating chromium pollution.
Novel synthesis method for axial chiral indole pyrrole-furan compounds with high enantioselectivity and yield, offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN118878452B reveals novel antitumor compound synthesis. Offers mild conditions and high yield for pharmaceutical intermediate supply chains. Enables cost reduction in API manufacturing.
Patent CN111217847A discloses stable thiosilane ligands for iridium-catalyzed borylation, offering superior yield and simplified purification for reliable pharmaceutical intermediate suppliers.
Patent CN114524701B details a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Patent CN120247882B reveals mild synthesis for antitumor compounds. Enables cost reduction in pharmaceutical manufacturing and high-purity API supply chain reliability.
Patent CN120172978B details a mild trifluoromethanesulfonic acid catalyzed method for dihydroquinolinopyrrole derivatives, offering cost reduction in pharmaceutical intermediate manufacturing and scalable supply chain solutions.
Novel chiral phosphoric acid catalysis enables high-yield indoline pyrrole synthesis. Cost-effective scalable production for pharmaceutical intermediates supply chain.
Novel organocatalytic synthesis of axially chiral 1-aryl indoles via spirophosphoric acid. Offers mild conditions and high enantioselectivity for glioma drug development.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production with reduced costs and scalable supply chain reliability for global pharma.
Novel chiral phosphoric acid catalysis enables efficient indolocyclopentanes synthesis. Offers high selectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Novel synthesis route for chiral indolo oxa rings offers high yield and enantioselectivity. Ideal for pharmaceutical intermediates manufacturing with reduced costs and scalable production capabilities.
Novel glucose-based route for triazole intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing processes globally.
Patent CN110452150A reveals a novel synthesis route. Offers high optical purity and mild conditions for reliable chiral pharmaceutical intermediate supply chains.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Novel chiral phosphoric acid catalysis for indolocyclopentanes. High yield, mild conditions, scalable for pharma intermediates. Reliable supply chain solutions.
Novel chiral phosphoric acid catalysis enables high yield synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115850216B reveals Rh-catalyzed route. Green water solvent ensures high purity and supply chain stability for global buyers.
Novel Ag-catalyzed route for 9,10-phenanthrene dicarboxylic esters offers mild conditions and high purity for reliable pharmaceutical intermediate supply chains.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.